Early Alzheimer's Disease Clinical Trial
Official title:
A Phase 2, Single-arm Study of the Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease Who Are Carriers of the ε4 Variant of the Apolipoprotein E Gene (APOE4/4 or APOE3/4)
The study will investigate the effects of oral ALZ-801, in subjects with Early AD who have the APOE4/4 or APOE3/4 genotype, on the biomarkers of core AD pathology. The objectives of this study include determining the efficacy and safety/tolerability of ALZ-801. In addition, the study will evaluate the extended PK profile over 8 hours in 16 subjects after 65 weeks of treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05122598 -
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
|
Phase 2 | |
| Active, not recruiting |
NCT04770220 -
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
|
Phase 3 | |
| Active, not recruiting |
NCT04777396 -
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
|
Phase 3 | |
| Active, not recruiting |
NCT03887455 -
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
|
Phase 3 | |
| Recruiting |
NCT05531656 -
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
|
Phase 2 | |
| Recruiting |
NCT04599764 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
|
N/A | |
| Completed |
NCT05161715 -
Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
|
Phase 2 | |
| Completed |
NCT02859207 -
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
|
Phase 1 | |
| Enrolling by invitation |
NCT06304883 -
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
|
Phase 3 |